Literature DB >> 15759532

Is it possible to actively and purposely make use of plasticity and adaptability in the neurorehabilitation treatment of multiple sclerosis patients? A pilot project.

K Rasova1, J Krasensky, E Havrdova, J Obenberger, Z Seidel, O Dolezal, P Rexova, M Zalisova.   

Abstract

OBJECTIVE: To investigate whether neurorehabilitation is able to influence clinical parameters and brain function measured radiologically.
DESIGN: A group of healthy probands was compared with two groups of multiple sclerosis (MS) patients, one of which received rehabilitative therapy.
SETTING: Outpatient in a university hospital.
SUBJECTS: Twenty-eight patients with multiple sclerosis (MS), 17 of whom received rehabilitative therapy, and 13 healthy controls.
INTERVENTIONS: Two months of rehabilitative eclectic therapy based on principles of sensorimotor learning and adaptation. MAIN MEASURES: Multiple Sclerosis Functional Composite, Modified Fatigue Impact Scale, Beck Depression Inventory Score, Barthel Index, Environment Status Scale and Multiple Sclerosis Quality of Life--54, and functional magnetic resonance imaging (fMRI).
RESULTS: Patients who underwent neurorehabilitation showed a greater drop in fatigue, depression, impairment, disability and handicap and more improvement in quality of life than those who did not receive therapy. Correlation of brain activity between the right and the left hemisphere is greater in healthy individuals than in MS patients. Neurorehabilitation resulted in a trend for increased correlation between the left and the right hemisphere in patients (approaching the standard). In comparison with control groups, signal amplitudes in anatomical areas did not show any significant changes.
CONCLUSION: Clinical changes seen with neurorehabilitation were not associated with any detectable changes in fMRI observations.

Entities:  

Mesh:

Year:  2005        PMID: 15759532     DOI: 10.1191/0269215505cr831oa

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  6 in total

1.  Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study.

Authors:  Eleonora Tavazzi; Niels Bergsland; Davide Cattaneo; Elisa Gervasoni; Maria Marcella Laganà; Ottavia Dipasquale; Cristina Grosso; Francesca Lea Saibene; Francesca Baglio; Marco Rovaris
Journal:  J Neurol       Date:  2018-04-07       Impact factor: 4.849

2.  Fractional anisotropy and mean diffusivity in the corpus callosum of patients with multiple sclerosis: the effect of physiotherapy.

Authors:  Ibrahim Ibrahim; Jaroslav Tintera; Antonin Skoch; Filip Jirů; Petr Hlustik; Patricia Martinkova; Karel Zvara; Kamila Rasova
Journal:  Neuroradiology       Date:  2011-05-10       Impact factor: 2.804

3.  Efficacy of inpatient personalized multidisciplinary rehabilitation in multiple sclerosis: behavioural and functional imaging results.

Authors:  Priska Zuber; Charidimos Tsagkas; Athina Papadopoulou; Laura Gaetano; Manuel Huerbin; Emanuel Geiter; Anna Altermatt; Katrin Parmar; Thierry Ettlin; Corina Schuster-Amft; Zorica Suica; Hala Alrasheed; Jens Wuerfel; Jürg Kesselring; Ludwig Kappos; Till Sprenger; Stefano Magon
Journal:  J Neurol       Date:  2020-03-02       Impact factor: 4.849

4.  Increased cerebral activation after behavioral treatment for memory deficits in MS.

Authors:  Nancy D Chiaravalloti; Glenn Wylie; Victoria Leavitt; John Deluca
Journal:  J Neurol       Date:  2012-01-12       Impact factor: 4.849

Review 5.  Functional and Structural Brain Plasticity Enhanced by Motor and Cognitive Rehabilitation in Multiple Sclerosis.

Authors:  Luca Prosperini; Maria Cristina Piattella; Costanza Giannì; Patrizia Pantano
Journal:  Neural Plast       Date:  2015-05-06       Impact factor: 3.599

6.  The Role of fMRI in the Assessment of Neuroplasticity in MS: A Systematic Review.

Authors:  De Giglio Laura; Tommasin Silvia; Petsas Nikolaos; Pantano Patrizia
Journal:  Neural Plast       Date:  2018-12-31       Impact factor: 3.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.